X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

ZO-1 Polyclonal Antibody

RRID:AB_2533457

Antibody ID

AB_2533457

Target Antigen

ZO-1 human

Proper Citation

(Thermo Fisher Scientific Cat# 40-2300, RRID:AB_2533457)

Clonality

polyclonal antibody

Comments

Applications: ICC (5-10 µg/mL), IF (2.5 µg/mL), IHC (Assay Dependent), IHC (P) (1-2 µg/mL), IHC (F) (2 µg/mL)

Clone ID

Clone ZMD.437

Host Organism

rabbit

Vendor

Thermo Fisher Scientific Go To Vendor

Cat Num

40-2300

Publications that use this research resource

Helicobacter pylori Infection Modulates Host Cell Metabolism through VacA-Dependent Inhibition of mTORC1.

  • Kim IJ
  • Cell Host Microbe
  • 2018 May 9

Literature context: Fisher Scientific Cat# 40-2300; RRID:AB_2533457 Rat monoclonal anti-Uvomorulin/


Abstract:

Helicobacter pylori (Hp) vacuolating cytotoxin (VacA) is a bacterial exotoxin that enters host cells and induces mitochondrial dysfunction. However, the extent to which VacA-dependent mitochondrial perturbations affect overall cellular metabolism is poorly understood. We report that VacA perturbations in mitochondria are linked to alterations in cellular amino acid homeostasis, which results in the inhibition of mammalian target of rapamycin complex 1 (mTORC1) and subsequent autophagy. mTORC1, which regulates cellular metabolism during nutrient stress, is inhibited during Hp infection by a VacA-dependent mechanism. This VacA-dependent inhibition of mTORC1 signaling is linked to the dissociation of mTORC1 from the lysosomal surface and results in activation of cellular autophagy through the Unc 51-like kinase 1 (Ulk1) complex. VacA intoxication results in reduced cellular amino acids, and bolstering amino acid pools prevents VacA-mediated mTORC1 inhibition. Overall, these studies support a model that Hp modulate host cell metabolism through the action of VacA at mitochondria.

Funding information:
  • NIAID NIH HHS - R01 AI045928()
  • NIAID NIH HHS - R21 AI117497()
  • NIAID NIH HHS - U19 AI106772(United States)
  • NIGMS NIH HHS - R01 GM089771()

The Strength of Mechanical Forces Determines the Differentiation of Alveolar Epithelial Cells.

  • Li J
  • Dev. Cell
  • 2018 Feb 5

Literature context: # 40-2300; RRID:AB_2533457 Rabbit anti-Cleaved caspase 3 C


Abstract:

The differentiation of alveolar epithelial type I (AT1) and type II (AT2) cells is essential for the lung gas exchange function. Disruption of this process results in neonatal death or in severe lung diseases that last into adulthood. We developed live imaging techniques to characterize the mechanisms that control alveolar epithelial cell differentiation. We discovered that mechanical forces generated from the inhalation of amniotic fluid by fetal breathing movements are essential for AT1 cell differentiation. We found that a large subset of alveolar progenitor cells is able to protrude from the airway epithelium toward the mesenchyme in an FGF10/FGFR2 signaling-dependent manner. The cell protrusion process results in enrichment of myosin in the apical region of protruded cells; this myosin prevents these cells from being flattened by mechanical forces, thereby ensuring their AT2 cell fate. Our study demonstrates that mechanical forces and local growth factors synergistically control alveolar epithelial cell differentiation.

Funding information:
  • Howard Hughes Medical Institute - (United States)

Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy.

  • Zhou W
  • Cell Stem Cell
  • 2017 Nov 2

Literature context: , RRID:AB_2533457 Occludin Santa Cruz Biotech. Ca


Abstract:

The blood-tumor barrier (BTB) is a major obstacle for drug delivery to malignant brain tumors such as glioblastoma (GBM). Disrupting the BTB is therefore highly desirable but complicated by the need to maintain the normal blood-brain barrier (BBB). Here we show that targeting glioma stem cell (GSC)-derived pericytes specifically disrupts the BTB and enhances drug effusion into brain tumors. We found that pericyte coverage of tumor vasculature is inversely correlated with GBM patient survival after chemotherapy. Eliminating GSC-derived pericytes in xenograft models disrupted BTB tight junctions and increased vascular permeability. We identified BMX as an essential factor for maintaining GSC-derived pericytes. Inhibiting BMX with ibrutinib selectively targeted neoplastic pericytes and disrupted the BTB, but not the BBB, thereby increasing drug effusion into established tumors and enhancing the chemotherapeutic efficacy of drugs with poor BTB penetration. These findings highlight the clinical potential of targeting neoplastic pericytes to significantly improve treatment of brain tumors.

Funding information:
  • NCI NIH HHS - R01 CA169117()
  • NCI NIH HHS - R01 CA184090()
  • NCRR NIH HHS - S10 RR031536()
  • NIH HHS - S10 OD018205()
  • NINDS NIH HHS - R01 NS091080()
  • NINDS NIH HHS - R01 NS092641()
  • NINDS NIH HHS - R01 NS094199()
  • NINDS NIH HHS - R01 NS099175()